Bleomycin - 63323-136-10 - (BLEOMYCIN)

Alphabetical Index


Drug Information of Bleomycin

Product NDC: 63323-136
Proprietary Name: Bleomycin
Non Proprietary Name: BLEOMYCIN
Active Ingredient(s): 15    [USP'U]/1 & nbsp;   BLEOMYCIN
Administration Route(s): INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Bleomycin

Product NDC: 63323-136
Labeler Name: APP Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA065185
Marketing Category: ANDA
Start Marketing Date: 20090213

Package Information of Bleomycin

Package NDC: 63323-136-10
Package Description: 1 VIAL in 1 CARTON (63323-136-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL

NDC Information of Bleomycin

NDC Code 63323-136-10
Proprietary Name Bleomycin
Package Description 1 VIAL in 1 CARTON (63323-136-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
Product NDC 63323-136
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name BLEOMYCIN
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20090213
Marketing Category Name ANDA
Labeler Name APP Pharmaceuticals, LLC
Substance Name BLEOMYCIN SULFATE
Strength Number 15
Strength Unit [USP'U]/1
Pharmaceutical Classes Cytoprotective Agent [EPC]

Complete Information of Bleomycin


General Information